|
Age, y
|
60 (52, 71)
|
62 (53, 72)
|
0.003
|
|
Male, n (%)
|
954 (73.1)
|
1089 (68.0)
|
<0.001
|
|
Tobacco use, n (%)
| | |
0.036
|
|
Never
|
692 (53.0)
|
928 (57.9)
| |
|
Quit
|
126 (9.7)
|
137 (8.6)
| |
|
Current
|
436 (33.4)
|
481 (30.0)
| |
|
Alcohol consumption, n (%)
| | |
0.006
|
|
Never
|
811 (62.1)
|
1064 (66.4)
| |
|
Mild
|
266 (20.4)
|
250 (15.6)
| |
|
Moderate to severe
|
192 (14.7)
|
256 (16.0)
| |
|
BMI(kg/m2)
|
24.6 (22.5,26.7)
|
24.5 (22.4,26.8)
|
0.637
|
|
NIHSS scales
| | |
<0.001
|
|
<9
|
1256 (96.2)
|
996 (62.2)
| |
|
9–18
|
30 (2.3)
|
474 (29.6)
| |
|
> 18
|
7 (0.5)
|
124 (7.7)
| |
|
Creatinine (m mol L−1)
|
72.7 (60.0, 87.5)
|
70.0 (57.5,85.0)
|
0.002
|
|
LDL(m mol L−1)
|
2.8 (2.3,3.5)
|
2.9 (2.3,3.5)
|
0.290
|
|
HDL(m mol L−1)
|
1.2 (1.0,1.4)
|
1.2 (1.0,1.4)
|
0.125
|
|
Systolic blood pressure (mmHg)
|
140 (130,160)
|
150 (134,161)
|
<0.001
|
|
Homocysteine (μmol L−1)
|
14.6 (11.4,19.8)
|
15.8 (12.3,21.4)
|
<0.001
|
|
HOMA2-IR
|
1.8 (1.1,3.0)
|
2.0 (1.2,3.1)
|
0.055
|
|
Past medical history, yes, n (%)
| | |
|
Coronary heart disease
|
146 (11.2)
|
203 (12.7)
|
0.230
|
|
Hypertension
|
785 (60.2)
|
994 (62.0)
|
0.296
|
|
Atrial fibrillation
|
53 (4.1)
|
98 (6.1)
|
0.013
|
|
Stroke types, n (%)
| | |
<0.001
|
|
Ischemic stroke
|
1059 (81.1)
|
1172 (73.2)
|
<0.001
|
|
Cardioembolic
|
44 (3.4)
|
91 (5.7)
| |
|
Large-artery atherosclerosis
|
565 (43.3)
|
819 (51.1)
| |
|
Small-artery occlusion Lacunar
|
367 (28.1)
|
200 (12.5)
| |
|
Other demonstrated or undemonstrated
|
38 (2.9)
|
25 (1.6)
| |
|
ICH
|
176 (13.5)
|
381(23.8)
| |
|
SAH
|
70 (5.4)
|
49 (3.1)
| |
|
Glycometabolism status
| | |
<0.001
|
|
Diabetes mellitus
|
500 (38.3)
|
720 (44.9)
| |
|
Prediabetes
|
348 (26.7)
|
429 (26.8)
| |
|
Normoglycaemia
|
457 (35.0)
|
453 (28.3)
| |
